Justyna M. Gawel - Concepedia

Author

Justyna M. Gawel

University of Toronto

Also Known As

Justyna M. Gawel

Publications

429

Citations

H-Index

Concepts

All Affiliations

University of Toronto MRC Mitochondrial Biology Unit University of Glasgow McMaster University University of Cambridge

About

Justyna M. Gawel is an author at University of Toronto specializing in oncology, radiation oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	76
2	Pharmacology	2	2	76
3	Health Sciences	1	1	40
4	Pathology	1	1	36
5	Cancer Therapeutics	1	1	36

Justyna M. Gawel

Publications

427

Citations

H-Index

Page 1

	Year	Citations
Selective superoxide generation within mitochondria by the targeted redox cycler MitoParaquat Ellen L. Robb, Justyna M. Gawel, Dunja Aksentijević, Free Radical Biology and Medicine	2015	145
Selective Disruption of Mitochondrial Thiol Redox State in Cells and In Vivo Lee M. Booty, Justyna M. Gawel, Filip Cvetko, Cell chemical biology	2019	52
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia Krimo Toutah, Nabanita Nawar, Sanna Timonen, Journal of Medicinal Chemistry	2021	43
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf, European Journal of Medicinal Chemistry Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology	2020	40
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer Andrew E. Shouksmith, Fenil Shah, Michelle Grimard, Journal of Medicinal Chemistry Hdac InhibitorsPathologyHdac DrugCancer BiologyTumor Biology	2019	36
Rapid and selective generation of H2S within mitochondria protects against cardiac ischemia-reperfusion injury Jan Lj. Miljković, Nils Burger, Justyna M. Gawel, Redox Biology	2022	36
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma Nabanita Nawar, Shazreh Bukhari, Ashley Adile, Journal of Medicinal Chemistry	2022	29
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype Olasunkanmi O. Olaoye, P. R. Watson, Nabanita Nawar, Journal of Medicinal Chemistry	2021	26
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia Andrew E. Shouksmith, Justyna M. Gawel, Nabanita Nawar, ACS Medicinal Chemistry Letters	2019	20

Page 1